Table 5.
Medical comorbidities evaluated for increased risk of actionable postoperative d 1 laboratory assessments.
| Postoperative d 1 comorbidities vs labs | Actionable BMP N = 955 (%) |
Actionable CBC N = 957 (%) |
|---|---|---|
| Hepatobiliary | 0 (0) | 2 (0.2), P = .254 OR: 2.7 [0.59-12.32] |
| Cardiac-HTN | 8 (0.8), P = .964 OR: 1.0 [0.35-2.98] |
8 (0.8), P = .963 OR: 1.1 [0.38-2.98] |
| Cardiac-Arrhythmia | 7 (0.7), P = .725 OR: 1.2 [0.42-3.47] |
7 (0.7), P = .719 OR: 1.2 [0.42-3.49] |
| Cardiac-CAD | 1 (0.1), P = .842 OR: 0.8 [0.11-6.32] |
3 (0.3), P = .137 OR: 3.1 [0.82-10.91] |
| Cardiac-CHF | 1 (0.1), P = .261 OR: 4.2 [0.52-33.80] |
2 (0.2), P = .025 OR: 9.7 [2.00-46.71] |
| Vascular or Hematologic | 4 (0.4), P = .726 OR: 0.8 [0.25-2.62] |
12 (1.3), P = .000 OR: 12.6 [2.81-56.70] |
| Renal | 4 (0.4), P = .992 OR: 1.0 [0.31-3.20] |
8 (0.8), P = .025 OR: 3.4 [1.17-9.87] |
| Respiratory | 3 (0.3), P = .987 OR: 1.0 [0.28-3.66] |
3 (0.3), P = .984 OR: 1.0 [0.28-3.67] |
| Metabolic-IDDM | 2 (0.2), P = .094 OR: 4.7 [1.02-22.04] |
2 (0.2), P = .094 OR: 4.8 [1.02-22.09] |
| Metabolic-NIDDM | 1 (0.1), P = .842 OR: 1.2 [0.16-9.65] |
0 (0) |
| Metabolic-DC Diabetes | 1 (0.1), P = .627 OR: 1.7 [0.22-13.57] |
0 (0) |
| Metabolic-Hyperlipidemia | 6 (0.6), P = .957 OR: 1.0 [0.33-2.82] |
3 (0.3), P = .081 OR: 0.4 [0.10-1.26] |
| Endocrine | 4 (0.4), P = .832 OR: 1.1 [0.35-3.66] |
7 (0.7), P = .055 OR: 2.9 [1.00-8.30] |
| Neoplastic | 1 (0.1), P = .473 OR: 0.5 [0.07-3.91] |
5 (0.5), P = .030 OR: 3.8 [1.26-11.56] |
| Immunologic | 1 (0.1), P = .978 OR: 1.0 [0.13-7.54] |
2 (0.2), P = .366 OR: 2.2 [0.47-9.78] |
| Nervous | 0 (0), P = .084 | 2 (0.2), P = .623 OR: 1.5 [0.33-6.75] |
| Gastrointestinal | 5 (0.5), P = .994 OR: 1.0 [0.33-3.00] |
5 (0.5), P = .999 OR: 1.0 [0.33-3.01] |
IDDM, non–insulin-dependent diabetes mellitus.
Bold values are statistically signficant.